Children prescribed anti-psychotic drug while in Kerry Camhs care settle actions
In one of the cases, the then almost 10-year-old boy gained 3.5kg in weight in the six months he was on the drug Risperidone, which the High Court heard was not appropriate and should not have been prescribed.
They had sued the HSE over the care they received at South Kerry Child and Adolescent Mental Health Services (Camhs). None of the children can be identified by order of the court.
The settlements were reached after mediation. Robert Fitzpatrick SC, with Siun Leonowicz BL, told the court the first boy had been referred to the Camhs service when he was under 10 years of age and he was prescribed the anti-psychotic drug Risperidone.
Counsel said the drug should never have been prescribed and it was dispensed for another five months in 2019. The young boy, he said, suffered side-effects, including weight-gain, and he had gained 3.5kg in weights over a 23-week period.
At one stage, counsel said the boy was prescribed an appetite-suppressant medication, which counsel said was also inappropriate.
Mr Fitzpatrick said the appetite suppressant medication appeared to be given in a misplaced effort to counteract the Risperidone, which should not have been prescribed. Counsel described it as a 'case of double error'.
Approving a €65,000 settlement in the teenager's case, Mr Justice Paul Coffey said it was fair and reasonable, and he wished the boy the best for the future.
In the second case, a 16-year-old boy settled his action for €75,000. Counsel said the boy when he was nine years old had been put on Risperidone and was taking it for five months in 2018. Counsel said the anti-psychotic was never appropriate for the child.
Counsel said the boy had been put on an ADHD medication which he had taken before and from which he previously suffered side-effects.
By putting the boy on the ADHD drug again, counsel said he had been needlessly put through side-effects. Approving the settlement, Mr Justice Paul Coffey conveyed his best wishes to the teenager.
In another case a 16-year old boy was awarded €17,500 in relation to his care at South Kerry Camhs. Counsel told the court the boy, when he was six years old, had been assessed by the service, diagnosed with ADHD and started on medication.
Counsel said his case related to a 23-month gap in later follow up. At one stage, counsel said the boy was prescribed the anti-psychotic drug Risperidone, but thanks ' to the good sense of his father, he never gave him the medication'. His case solely related to lost follow-up.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RTÉ News
3 days ago
- RTÉ News
Decline in use of restrictive practices at mental health centres
There has been a significant decline in the use of restrictive practices - such as seclusion and physical restraint - across Irish mental health services in the past seven years. A report by the Inspector of Mental Health Services shows that the number of restrictive episodes in approved mental health centres fell by 62% from 2018 to 2024. There has also been a 91% reduction in seclusion and physical restraint in Child and Adolescent Mental Health Services (CAMHS) over the same period. In January 2023, the Mental Health Commission banned the use of mechanical restraint on children. There was an 80% decrease in seclusion episodes and a 57% decrease in physical restraint episodes in CAMHS approved centres between 2023 and 2024. In the report, Professor Jim Lucey said children were "specifically protected" from restrictive practices in Irish mental health care through a human rights-based approach." Overall, the rate of decline in seclusion episodes in 2023 and 2024 was almost twice that seen in the preceding four years. Similarly, the rate of reduction in the number of people physically restrained between 2023 and 2024 was twice that seen in the preceding four years. The majority of episodes of physical restraint in 2023 (97.4%) and 2024 (97.9%) were ten minutes or less. Over three quarters lasted five minutes or less. Two approved centres reported use of mechanical restraint in 2023, and one in 2024. Revised rules introduced a maximum duration of four hours for an order of mechanical restraint for immediate risk. All episodes in 2023 and 2024 were described as being used for "transfer purposes to and from court/hospital" where there was an immediate threat of serious harm.
Irish Times
3 days ago
- Irish Times
HSE paid medical products company €720,000 twice for the same invoice
A company paid more than €720,000 twice by the Health Service Executive (HSE) on foot of the same invoice is now in liquidation. The HSE said it was 'engaged with the liquidator to recover and resolve this overpayment, among other matters'. So far the overpayment has not been recouped. The HSE said that, at the time of the liquidation, the company had maintained it was owed additional money by the health service but this was not paid 'pending the resolution of the double payment issue and other matters'. The HSE identified the company that received the two payments as PMD Device Solutions Ltd. READ MORE In February, PMD Device Solutions Ltd petitioned the High Court for the appointment of provisional liquidators, acknowledging it was 'clearly insolvent', with more than €14.6 million in liabilities set against €4.6 million in assets. The company claimed it was owed approximately €1.2 million by the HSE and had issued High Court proceedings against the health authority. This is being contested. The liquidator did not respond to a request for comment. The Irish Times reported on Friday that the HSE financial report for 2024 showed one company had been paid more than €720,000 from two different parts of the health service on foot of the same invoice. No cross-checking had been carried out. 'The payments were made from two legacy areas [that] were previously on separate ledgers managed by different HSE staff,' it said, adding that the HSE now has an integrated financial and procurement system. [ Provisional liquidators appointed to Cork medical supplies company Opens in new window ] PMD Device Solutions was established in Co Cork in October 2011. It developed medical products for respiratory monitoring. In early 2024 the then minister of state at the Department of Finance, Jennifer Carroll MacNeill, now Minister for Health, attended a ceremony to ring the bell at the Nasdaq Stockholm exchange in Sweden to mark an acquisition involving the company. The HSE annual report, published last Friday, says the supplier paid twice had entered into an arrangement with the health service in 2020 for the supply of diagnostic devices, ancillary supplies and information technology. It says the overall system 'was considered to be of significant value in monitoring the condition of Covid-19 patients in hospital settings'. The supplier received about €15 million between 2020 and 2024. It says the arrangement was initially put in place on an emergency basis during the pandemic and was never then regularised through an appropriate competitive tendering process. The report says different HSE units were invoiced from time to time. 'This included prepayment each quarter from mid-2022 to mid-2024 for supply of a standard number of devices, to be drawn down as required by individual hospitals.' The report says the HSE did not maintain central records of the total number of units paid for, and the number of devices received by hospitals, or paid for and remaining undrawn from the supplier, is not known. 'The executive also does not know how many of the items paid for were actually used in its hospitals.' Separately, the HSE this week provided more details on the write-off of what its financial accounts described as an 'asset' constructed in 2009 at a cost of €1.4 million. It was never used for its intended purposes and was written off last year at a cost of €800,000, according to the accounts. The HSE said the write-off related to a planned initiative to develop a hydrotherapy pool. 'A number of factors arising meant that it could not come to fruition and the space was given over to the further capital development of essential clinical capacity. This capital development has delivered six additional outpatient consulting rooms, expanded clinical storage, and hot desk facilities for clinical staff,' the HSE said.
Irish Times
4 days ago
- Irish Times
Children prescribed anti-psychotic drug while in Camhs care settle High Court actions
Two teenagers who were prescribed an antipsychotic drug while undergoing treatment with the South Kerry Child and Adolescent and Mental Health Services (Camhs) have settled their High Court actions for a total of €135,000. In one of the cases, the then nine-year-old boy gained 3.5kg in weight in the six months he was on the drug, Risperidone, which the High Court heard was not appropriate and should not have been prescribed. They had sued the HSE over the care they received at South Kerry Camhs. None of the children can be identified by order of the court. The settlements were reached after mediation. Robert Fitzpatrick SC with Siun Leonowicz BL told the court that the first boy had been referred to the Camhs service when he was under 10 years of age and he was prescribed the antipsychotic drug Risperidone. READ MORE Counsel said the drug should never have been prescribed, and it was dispensed for another five months in 2019. The young boy, he said, suffered side effects including weight gain and he had gained 3.5kg over a 23-week period. At one stage, counsel said the boy was prescribed an appetite suppressant medication which was also inappropriate. Mr Fitzpatrick said the appetite suppressant medication appeared to be given in a misplaced effort to counteract the Risperidone, which should not have been prescribed. Counsel described it as a 'case of double error.' Approving a €60,000 settlement in the teenager's case, Mr Justice Paul Coffey said it was fair and reasonable, and he wished the boy the best for the future. In the second case, a 16-year-old boy settled for €75,000. Mr Fitzpatrick said the boy, when he was nine years old, had been put on Risperidone and was taking it for five months in 2018. Counsel said the antipsychotic was never appropriate for the child. Counsel said the boy had been put on an ADHD medication which he had taken before and from which he previously suffered side effects. By putting the boy on the ADHD drug again, counsel said he had been needlessly put through side effects. Approving the settlement, Mr Justice Coffey conveyed his best wishes to the teenager. In a third case, a 16-year-old boy was awarded €17,500 in relation to his care at South Kerry Camhs. Mr Fitzpatrick told the court that the boy when he was six years old had been assessed by the service, diagnosed with ADHD and started on medication. Counsel said his case related to a 23-month gap in later follow up. At one stage counsel said the boy was prescribed the antipsychotic drug Risperidone but thanks 'to the good sense of his father, he never gave him the medication.' His case solely related to lost follow up.
